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Background: The effects of curcumin on the activities and gene expression of antioxidant enzymes, superoxide
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione-S-transferase (G-ST), B-cell CLL/lymphoma
2 (Bcl-2) and insulin like growth factor-1 (IGF-1) in diabetic rats were studied.
Methods: Twenty four rats were assigned to three groups (8 rats for each). Rats of first group were non diabetic
and rats of the second group were rendered diabetic by streptozotocin (STZ). Both groups received vehicle, corn oil
only (5 ml/kg body weight) and served as negative and positive controls, respectively. Rats of the third group were
rendered diabetic and received oral curcumin dissolved in corn oil at a dose of 15 mg/5 ml/kg body weight for
6 weeks.
Results: Diabetic rats showed significant increase of blood glucose, thiobarbituric acid reactive substances (TBARS)
and activities of all antioxidant enzymes with significant reduction of reduced glutathione (GSH) compare to the
control non diabetic group. Gene expression of Bcl2, SOD, CAT, GPX and GST was increased significantly in diabetic
untreated rats compare to the control non diabetic group. The administration of curcumin to diabetic rats
normalized significantly their blood sugar level and TBARS values and increased the activities of all antioxidant
enzymes and GSH concentration. In addition, curcumin treated rats showed significant increase in gene expression
of IGF-1, Bcl2, SOD and GST compare to non diabetic and diabetic untreated rats.
Conclusion: Curcumin was antidiabetic therapy, induced hypoglycemia by up-regulation of IGF-1 gene and ameliorate
the diabetes induced oxidative stress via increasing the availability of GSH, increasing the activities and gene expression
of antioxidant enzymes and Bcl2. Further studies are required to investigate the actual mechanism of action of
curcumin regarding the up regulation of gene expression of examined parameters.
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Diabetes is one of the most common chronic diseases af-
fecting more than 100 million people world wide. The
two major types of diabetes mellitus are characterized by
hyperglycemia, abnormal lipid and protein metabolism
along with specific long term complications affecting theCorrespondence: sabryelbahr@hotmail.com
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reproduction in any medium, provided the orretina, kidney and nervous system [1]. Hyperglycemia is
an important factor in the development and progression
of the complications of diabetes mellitus [2]. Hypergly-
cemia caused an increase in glucose autoxidation, pro-
tein glycation and the subsequent oxidative degradation
of glycated protein leads to enhanced production of re-
active oxygen species (ROS) [3]. The levels of ROS are
regulated by a variety of cellular defense mechanisms
consisting of enzymic and non-enzymic antioxidants [4].
The primary scavenger enzymes involved in detoxifying
ROS in mammalian systems are CAT, SOD, GPX andhis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fect of diabetes-induced hyperglycemia on antioxidant
enzymes are contradictory. They have been reported to
decrease, increase or remain unaltered in diabetic ani-
mals with wide variations depending on age of the ani-
mal or duration of diabetes [6-8] or tissues examined
[9,10]. These discrepancies may arise due to variations
in enzyme activity over time (e.g. compensatory in-
creases in enzyme activity to overcome raised oxidative
stress or direct inhibitory effects of ROS as well as due
to the type of tissue under examination). High levels
and/or inadequate removal of ROS may cause severe
metabolic imbalance and oxidative damage to biological
macromolecules named oxidative stress [5]. Oxidative
stress often causes cell death via apoptosis that is regu-
lated by certain functional genes and their protein prod-
ucts. Bcl-2, which is an integral mitochondrial membrane
protein, blocks apoptosis induced by a wide array of death
signals and is involved in decreasing ROS production [11].
Bcl-2 protein itself has antioxidant ability either by pre-
vention of entrance of cytochrome c to the cytosol or by
binding directly with cytochrome c to reduce generation
of free radicals [12]. Furthermore, Bcl-2-overexpressing
cells exhibit elevated expression of antioxidant enzymes
and higher levels of cellular GSH [13]. IGF-1 is a peptide
hormone and has structural homology with insulin. Liver
is the main source of circulating IGF-1 [14]. IGF-1 is
widely present in tissues of mammalian animals and
has a number of bioactivities including regulation of
metabolism and enhancement of growth and develop-
ment of tissues [15]. IGF-1 may probably be involved
in the metabolic abnormalities and complications asso-
ciated with diabetes [16]. IGF-1 maintain euglycemia
by increasing the peripheral uptake of glucose and fatty
acids and decreasing the insulin resistance [17]. IGF-1
augments the peripheral glucose uptake via binding to
normal IGF-1 receptors mainly in muscle tissues. How-
ever, with worsening of insulin resistance, the expression
of hybrid receptors in muscle and adipose tissues are
increased and leads to increased glucose and fatty acids
uptake in these tissues [17]. The effect of IGF-1 on pan-
creatic β-cells also was also documented. β-cells express
the IGF-1 receptors and tyrosine kinase activity of these
receptors on the insulin receptor substrate pathway could
potentially alter insulin secretion by influencing cell repli-
cation and survival [17].
There are many anti-diabetic plants, which might pro-
vide useful sources for the development of drugs, in the
treatment of diabetes mellitus. The literature on medi-
cinal plants with hypoglycemic activity is vast. As many
of these plants were used for many centuries and some
times as regular constituents of the diet, it is assumed
that they do not have many side effects. However
chronic consumption of large amounts of traditionalremedies must always be taken with caution as tox-
icity studies have not been conducted for most of
these plants [18,19]. Curcumin, the active ingredient
from the spice turmeric is a potent antioxidant and
anti-inflammatory agent with hepatoprotective, anti-
carcinogenic and antimicrobial properties [20,21].
Curcumin also has a beneficial effect on blood glu-
cose in diabetics and increases gastric mucosal secre-
tion in rabbits [22]. The Turmeric rhizomes have
been reported to possess antidiabetic properties as its
alcohol extract possesses active constituents showing
blood glucose lowering activity in alloxan induced
diabetic rats [18]. Although, the antidiabetic effects
of curcumin have been extensively studied on periph-
eral blood [23], the literature reports are still contra-
dictory. In addition, the molecular studies regarding
the effect of curcumin on gene expression of antioxi-
dant enzymes have not been clearly elucidated. Add-
itionally, the effect of curcumin on gene expression
of Bcl-2 and IGF-1 was not determined so far. Upon
this basis, streptozotocin diabetic rats were used in
the present study to evaluate the effects of curcumin
on activities and gene expression of antioxidant en-
zymes. Furthermore, the effect of curcumin on gene
expression of Bcl-2 and IGF-1 in streptozotocin-
induced diabetes in rats was also determined.Methods
Chemicals
Curcumin, streptozotocin, agarose, ethidium bromide,
chloroform, and isopropanol were purchased from Sigma
Chemical Co., MO, USA. The glucotest strips were sup-
plied by Roche, USA. The DNA ladder was purchased
from MBI, Fermentas, USA. Primers were purchased from
metabion international Ag, Germany. One step RT-PCR
kits were purchased from Qiagen Germany. TriZol re-
agent was supplied by Invitrogen, Carlsbad, CA. Quan-
tiFast™ SYBR Green PCR Master Mix kit was supplied by
QIAGEN, Hilden; Germany. All other chemicals were of
the highest analytical grade.Experimental animals
A total of twenty four adult albino rats weighing be-
tween 200 ± 15 g were maintained as performed by na-
tional guidelines and protocols, approved by the King
Faisal University Scientific Research Ethics Committee.
They were housed in clean and disinfected cages. Com-
mercial basal diet and water were provided ad libitum.
Rats were subjected to natural photoperiod of 12 hr
light:dark cycle throughout the experimental period
(6 weeks). All rats received basal diet for two weeks
before the start of the experiment for adaptation and
to ensure normal growth and behavior.
El-Bahr BMC Complementary and Alternative Medicine 2013, 13:368 Page 3 of 11
http://www.biomedcentral.com/1472-6882/13/368Induction of experimental diabetes
Diabetes was induced by administering intraperitonial
injection of a freshly prepared solution of STZ (60 mg/kg
b. w.) in 0.1 M cold citrate buffer (pH 4.5) to the overnight
fasted rats [24]. Because of the instability of STZ in aque-
ous media, the solution was made using cold citrate buffer
(pH 4.5) immediately before administration. Control rats
were injected with citrate buffer alone. The rats were
allowed to drink 5% glucose solution overnight to over-
come the drug-induced hypoglycemia. After 72 hours,
fasting blood glucose levels were monitored. Animals hav-
ing blood glucose levels 145 mg/dl were excluded from
the experiment and animals having blood glucose values
above 250 mg/dl on the third day after STZ injection were
considered as diabetic rats [25]. Then the treatment was
started on the third day after STZ injection and it was
considered as first day of treatment.
Experimental design
Rats were divided into three groups (8 rats for each).
The first group (group I) served as control and received
vehicle, corn oil only (5 ml/kg body weight). Rats of the
second group (group II) rendered diabetic by administer-
ing intraperitonial injection of a freshly prepared solution
of STZ (60 mg/kg b. w.) in 0.1 M cold citrate buffer
(pH 4.5) to the overnight fasted rats [24]. Rats of the third
group (group III) rendered diabetic and received curcumin
dissolved in corn oil at a dose of 15 mg/5 ml/kg body
weight for 6 weeks by gastric gavages [26,27].
Samples collection and blood glucose level estimation
Blood samples were collected from the fasted rats of three
groups prior to the treatment with curcumin and four
times after oral administration of the treatments up to
6 weeks (first, second, fourth and sixth weeks). Blood sam-
ples were collected by snipping tail with sharp razor and
blood glucose level was then measured immediately by glu-
cose strips (haemo-glucotest). At the end of the experi-
ment, liver samples were collected from all groups, washed
by normal saline solution, dried by towel, flash frozen in li-
quid nitrogen and subsequently frozen at –80°C until the
time of analysis of oxidative stress biomarkers, RT-PCR
and real time RT-PCR.
Determination of hepatic antioxidant enzymes,
thiobarbituric acid reactive substances and reduced
glutathione
One gram of liver tissues was homogenized in 5 ml of
cold 20 mM HEPES buffer, pH 7.2, containing 1 mM
EGTA, 210 mM mannitol and 70 mM sucrose. After
centrifugation (1500 × g/5 minute at 4°C, the supernatant
was removed and stored frozen at –80°C until the time of
analysis of SOD. Another one gram of liver tissues was
homogenized in 5 ml of cold buffer of 50 mMpotassium phosphate buffer, pH 7, containing 1 mM
EDTA. After centrifugation at 10.000 × g/15 minutes
at 4°C, the supernatant was removed and stored fro-
zen at –80°C until the time of analysis of CAT, GPX,
GST, GR and GSH. The extent of lipid peroxidation
in terms of thiobarbituric acid reactive substances
(TBARS) formation was measured by mixing one
gram of liver tissues with RIPA buffer (Item No.
10010263, Cayman chemical company, USA). After
homogenization, sonication and centrifugation (1600 × g/
10 minutes), the supernatant was removed and stored
frozen at -80°C until the time of analysis. The activities
of CAT (nmol/min/gram tissue; Cayman Chemical
Company, USA, Catalog No. 707002), GPX (nmol/min/
gram tissue; Cayman Chemical Company, USA, Catalog
No. 703102), SOD (U/gram tissue; Cayman Chemical
Company, USA, Catalog No. 706002), GST (nmol/min/
gram tissue; Cayman Chemical Company, USA, Catalog
No. 703302) and concentrations of GSH (μM; Cayman
Chemical Company, USA, Catalog No. 703002) and TBARS
(μM; Cayman Chemical Company, USA, Catalog No.
10009055) were determined by ELISA reader (Absorbance
Microplate Reader ELx 800TM BioTek®, USA). Results
were calculated according to the manufacture
instructions.
Total RNA isolation and RT-PCR analysis of hepatic
antioxidant enzymes, Bcl-2 and IGF-1
The Primers of GPX, CAT and SOD [28] as well as IGF-
1 and β-actin genes [29] and Bcl-2 [30] were taken from
literature. The primers were checked for their Tm values,
hairpin loops, dimers, cross- dimers and number of re-
peats and runs using Net Primer (Oligoanalyzer 3.1).
β-actin gene was used as an internal standard (house
keeping gene). Frozen liver samples (approximately 1 g
per sample) were immediately added to lysis buffer
(Qiagen, Germany) and homogenized using homogenizer
(Tissue Ruptor, Qiagen GmbH, Germany). Reverse tran-
scriptase polymerase chain reaction (RT-PCR) was per-
formed with Qiagen one-step RT-PCR kit (Qiagen,
Germany) according to the manufacturer’s instructions.
The purity of RNA at 260/280 OD ratio and RNA in-
tegrity was evaluated using Multi-Mode Microplate
reader (SYNERGY Mx, BIO-TEK. Winooski, Vermont,
USA). Only high purity samples (OD260/280 >1.8)
were subjected to further manipulation. The master
mix was prepared according to the manufacture in-
struction. The whole volume of the reaction was 25 μl
for each gene of interest arranged as 5 μl of 5× buffer,
5 μl of Q-buffer, 1 μl of dTNPs, 1 μl of forward primer,
1 μl of the reverse primer, 1 μl of enzyme mix (reverse
transcriptase and Taq polymerase), 6 μl of nuclease
free water and finally 5 μl of RNA. The reaction has
been done in a Bio-Rad thermal cycler (MyCycler,
El-Bahr BMC Complementary and Alternative Medicine 2013, 13:368 Page 4 of 11
http://www.biomedcentral.com/1472-6882/13/368Germany). The RT-PCR conditions were as follows: (1)
reverse transcription, 30 min, 50°C, (2) initial PCR ac-
tivation step, 15 min, 95°C, (3) 3-step cycling for 40 cy-
cles, each cycle consisting of denaturation for 30 sec at
94°C followed by annealing for 30 sec at 52-57°C (ac-
cording to gene of interest as described in Table 1) and
extension for 1 min at 72°C. The template concentra-
tion and the cycle number were optimized to ensure
linearity of response and to avoid saturation of the
reaction (40 cycle was better). The PCR products
were then resolved on 1.5% agarose gels. The bands
were identified based on the product size using a
5000 bp DNA ladder; Documented using a Gel docu-
mentation system (Gel DocTMXR System, Bio-Rad)
and the prints were scanned. The scanned images
were quantified densitometrically with the aid of NIH
image program (http://rsb.info.nih.gov/nih-image/). The
results were normalized to the levels obtained for the
β-actin gene by taking a ratio of the value obtained
for the gene of interest to that of β-actin and then
relative to the control.
Total RNA isolation and Real time RT-PCR analysis of
hepatic antioxidant enzymes, Bcl-2 and IGF-1
Liver tissues (approximately 1 g of tissue per sample) were
immediately added to 1 ml of TriZol reagent (Invitrogen,
Carlsbad, CA) and homogenized using homogenizer (Tis-
sue Ruptor, Qiagen GmbH, Germany). One milliliter of
the tissue homogenate was transferred to a microfuge tube
and total RNA was extracted by adding 0.2 ml chloroform.
Afterwards, samples were vortexed vigorously for 15 seconds
and incubated at room temperatuer for 3 minutes. After
centrifugation (12,000 g/15 minutes) at 4°C, the aqueous
phase containing RNA was transfered into new tubes. RNATable 1 Details giving primer sequences and expected produ
cDNA Sequence Anne
β-actin F 5/-AGC CAT GTA CGT AGC CAT CC-3/
β-actin R 5/- CTC TCA GCT GTG GTG GTG AA-3/
IGF1F 5/- CTG GGT GTC CAA ATG TAA CT-3/
IGF1R 5/-GTA TCT TTA TTG GAG GTG CG-3/
SODF 5/- AGG ATT AAC TGA AGG CGA GCA T-3/
SODR 5/- TCT ACA GTT AGC AGG CCA GCA G-3/
CATF 5/-ACG AGA TGG CAC ACT TTG ACA G −3/
CATR 5/-TGG GTT TCT CTT CTG GCT ATG G-3/
GPxF 5/-AAG GTG CTG CTC ATT GAG AAT G-3/
GPxR 5/-CGT CTG GAC CTA CCA GGA ACT T-3/
Bcl-2 F 5/- TCC ATT ATA AGC TGT CAC AGA GG-3/
Bcl-2R 5/- GAA GAG TTC CTC CAC CAC C-3/
GSTF 5/- GCT GGA GTG GAG TTT GAA GAA-3/
GSTR 5/- GTC CTG ACC ACG TCA ACA TAG-3/was precipited by mixing the aqueous phase with 0.5 ml iso-
propyl alcohol and incubated at room temperuter for 10 mi-
nutes. After centrifugation at 12,000 g for 10 minutes at 4°C,
RNA pellets were washed by mixing and vortexing with
1 ml of 75% ethanol. After centrifugation (7.500 g/5 minutes)
at 4°C, RNA pellets were resuspended in nuclease free water
(Life Technologies. USA). The purity of RNA at 260/280
OD ratio and RNA integrity has been estimated as described
above in RT-PCR analysis. cDNA was prepared from RNA
samples according to Revers Transcription System Kit (Pro-
mega, Madison, USA) by using Bio-Rad Thermal Cycler
(T100™, Foster city, California, USA). Briefly, total RNA were
activated at 70°C for 10 minutes and 20 μl reaction mix were
made of 4 μl MgCl2, 2 μl of reverse transcription 10× buffer,
2 μl of dNTP mixture (10 mM), 0.5 μl of random primers,
0.75 μl of AMV reverse transcriptase enzyme, 1 ng RNA
and nuclease-free water to a final volume of 20 μl. Then the
reaction was incubated at 42°C for 60 minutes followed by
incubation at 94°C for 5 minutes. cDNA was diluted
up to 100 μl with nuclease-free water for PCR amplifi-
cation. Real time RT-PCR was performed using Quan-
tiFast™ SYBR Green PCR Master Mix kit (QIAGEN,
Hilden; Germany). The 25 μl reaction for each exam-
ined gene was prepared from 12.5 μl of master mix;
2 μl forwerd primer (10 pmol); 2 μl revers primer (10
pmol); 2 μl cDNA of the sample and 6.5 μl of
nuclease-free water. Cycling parameters were, 50°C for
2 minutes, 95°C for 15 minutes, 40 cycles of 95°C for
10 seconds, followed by 55°C for 30 seconds and 72°C for
10 seconds with final melting at 95°C for 20 seconds. For
each gene examined, duplicate samples from each cDNA
analyzed by real time RT-PCR using the Bio-Rad CFX
Manager 3.0 Software of the C1000 Touch thermal cycler-
CFX96 Real time PCR (BIO-RAD, Foster city, California,ct size for the genes amplified








Table 3 Effect of oral administration of curcumin for six
weeks on lipid peroxidation, reduced glutathione and
antioxidant enzyme activities in streptozotocin induced
diabetic rats
Group I Group II Group III
TBARS (μM) 34.6 ± 0.05 42.9 ± 0.1* 32.6 ± 0.09#
CAT (nmol/min/gram tissue) 23.2 ± 0.10 32.6 ± 0.2* 31.1 ± 1.50*
SOD (U/gram tissue) 6.1 ± 0.03 7.2 ± 0.1* 8.3 ± 0.07*#
GPX (nmol/min/ gram tissue) 209.0 ± 1.2 220.4 ± 2.1* 323.0 ± 3.20*#
GST (nmol/min/ gram tissue) 163.0 ± 1.1 175.2 ± 2.0* 260.1 ± 3.10*#
GSH (μM) 4.8 ± 0.2 3.1 ± 0.1* 8.7 ± 0.10*#
Group I (non diabetic), group II (diabetic), group III (diabetic treated with
curcumin); Values are mean ± SD of 8 rats; TBARS: thiobarbituric acid reactive
substances; CAT: catalase; SOD: superoxide dismutase; GST: glutathione-S
transferase; GSH: reduced glutathione.
*Mean values are significantly (P < 0.05) different compare to the control
(group I). #Mean values are significantly (P < 0.05) different compare to
diabetic rats (group II).
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keeping gene to normalize the expression data. The pri-
mer sequences are the same of conventional PCR
technique as described above (Table 1).
Statistical analysis
All data was presented as mean ± standard error of mean
by using student-t test. All tests were performed using
computer package of the statistical analysis system [31].
The relative gene expression of target genes in compari-
son to the β-actin reference gene was calculated using
the Bio-Rad CFX Manager 3.0 Software of the C1000
Touch thermal cycler-CFX96 Real time PCR (BIO-RAD,
Foster city, California, USA).
Results
Blood glucose level estimation
The results for the effects of curcumin on blood glucose
concentration of STZ diabetic rats are shown in Table 2.
At the start of the experiment or at zero time, there
were no statistically significant (P > 0.05) differences in
the mean values of blood glucose level between all ex-
perimental groups. After injection of STZ, the mean
values of blood glucose levels in untreated diabetic rats
(group II) were remained above 330 mg/dl during the en-
tire period of the study, which were significantly (P < 0.05)
higher than those of the non diabetic normal control rats
by approximately 230%. The percentage of increase in glu-
cose level of diabetic rats (230%) was reduced by 39.7%
(199 mg/dl) as result of curcumin administration.
Hepatic antioxidant enzymes, thiobarbituric acid reactive
substances and reduced glutathione
The results for the effect of curcumin on lipid peroxida-
tion, GSH and antioxidant enzyme activities of STZ dia-
betic rats are illustrated in Table 3. The current results
revealed that, lipid peroxidation (TBARS values) increased
significantly (P < 0.05) by 19.3% in diabetic untreated rats
(42.9 ± 0.1 μM) compare to control non diabetic rats
(34.6 ± 0.05 μM). However, administration of curcumin to
diabetic rats normalized these TBARS values (32.6 ±Table 2 Effect of oral administration of curcumin at the start
and during six weeks of the experiment on blood glucose
concentration (mg/dl) in streptozotocin diabetic rats
Groups Blood glucose concentration (mg/dl)
At the start 1st week 2nd week 4th week 6th week
I 100 ± 1.1 100 ± 2.1 96 ± 1.2 92 ± 1.1 90 ± 2.1
II 102 ± 1.2 366 ± 1.9* 330 ± 1.5* 340 ± 1.4* 350 ± 1.7*
III 98.2 ± 2.1 199 ± 1.1** 187 ± 1.0** 192 ± 1.3** 197 ± 1.2**
I (non diabetic), II (diabetic), III (diabetic treated with curcumin); Values are
mean ± SD of 8 rats; *Mean values are significantly (P < 0.05) different compare
to the control (group I). **Mean values are significantly (P < 0.05) different
compare to diabetic rats (group II).0.09 μM). In diabetic untreated rats, the activities of CAT
(32.6 ± 0.2 nmol/min/gm tissues), SOD (7.2 ± 0.1 U/gm
tissue), GPX (220.4 ± 2.1 nmol/min/gm tissues) and
GST (175.2 ± 2.0 nmol/min/gm tissue) enzymes were
increased significantly (P < 0.05) compare to control
(23.2 ± 0.1 nmol/min/gm tissues; 6.1 ± 0.03 U/gm tissue;
209 ± 1.2 nmol/min/gm tissues; 163.0 ± 1.1 nmol/min/gm
tissue), respectively. With the exception of CAT, the ad-
ministration of curcumin caused significant (P < 0.05) in-
crease in the activities of these enzymes (SOD: 8.3 ± 0.07
U/gm tissue; GPX: 323 ± 3.2 nmol/min/gm tissues; GST:
260.1 ± 3.1 nmol/min/gm tissues) compare to diabetic un-
treated rats. It is statistically obvious that, the activities of
SOD, GPX and GST were increased significantly (P < 0.05)
approximately by 13.3%, 31.8% and 32.6%, respectively in
diabetic rats treated with curcumin compare to control
non diabetic rats and increased significantly (P < 0.05) ap-
proximately by 26.5%, 35.3% and 37.3%, respectively in dia-
betic rats treated with curcumin compare to diabetic
untreated rats. The concentration of GSH was de-
creased significantly (P < 0.05) in diabetic untreated rats
(3.1 ± 0.1 μM) compare to control non diabetic rats (4.8 ±
0.2 μM). Interestingly, The concentration of GSH was in-
creased significantly by approximately 44.8% and 64.4% in
diabetic rats treated with curcumin compared with nondi-
abetic and diabetic untreated rats, respectively.
RT-PCR analysis of hepatic antioxidant enzymes, Bcl-2 and
IGF-1
The RT-PCR data as showed in Figure 1a indicated that,
experimental diabetes by STZ did not affect (p > 0.05)
the gene expression of IGF-1 compare to control non
diabetic rats. Over expression of this gene was induced
when diabetic rats treated with curcumin compare to
control non diabetic and diabetic untreated rats. RT-PCR






















































































































Figure 1 RT-PCR analysis of IGF-1 (a), Bcl2 (b), SOD (c), CAT (d) in liver tissues of control non diabetic (C), experimentally diabetic
(D) and Curcumin (Cur) treated diabetic rats. RT-PCR was performed with Qiagen one-step. The densitometric analysis of the expresses
bands (lower columns) was normalized with that of β-actin and then calculated as relative to the control group. Values are expressed as
mean ± SEM for 8 rats. *Values are significant different (p < 0.5) compared to control non diabetic group. #Values are significant different
(p < 0.5) compared to control diabetic group.
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Bcl2, SOD, CAT and GPX as explained in Figure 1b, 1c,
1d and Figure 2a, respectively without significant effect on
gene expression of GST (Figure 2b). The RT-PCR data
with regards to effect of curcumin indicated that, curcu-
min administration induced significant increase in mRNA
expression of Bcl2 (Figure 1b) and SOD (Figure 1c) com-
pare to control non diabetic and diabetic untreated rats.
In addition, curcumin induced up-regulation of CAT and
GPX gene expression compare to control non diabetic rats
but remained comparable to that induced by STZ com-
pare to diabetic rats.
Real time RT-PCR analysis of hepatic antioxidant
enzymes, Bcl-2 and IGF-1
The real time PCR analysis was parallel to that observed
by RT-PCR for gene expression of IGF-1, Bcl2, SOD,
CAT and GPX (Figures 3 and 4). However, real time
analysis indicated that, experimental diabetes by STZincreased significantly (p < 0.05) the gene expression of
GST compare to control non diabetic rats (Figure 4b)
and curcumin administration induced significant in-
crease in the expression of this gene (Figure 4b) com-
pare to control non diabetic and diabetic untreated rats.
Discussion
The present findings revealed that, injection of STZ
(60 mg/kg b.wt.) induced significant hyperglycemia in
rats. This dose caused damage to β-cells of the islets of lang-
erhans and emergence of clinical diabetes within 2–4 days
as results of autoimmune process [32]. Similar to the
present findings, previous articles [33,34] reported that, STZ
induced significant hyperglycemia. Hyperglycemia may be
attributed to enhancement of gluconeogenesis as a result of
absence of insulin [35]. The hypoglycemic effect of
curcumin observed in the current study comes in ac-
cordance with those obtained in rats [22,36]. Authors


























































Figure 2 RT-PCR analysis of GPX (a) and GST (b) in liver tissues of control non diabetic, experimentally diabetic and curcumin (Cur)treated
diabetic rats. RT-PCR was performed with Qiagen one-step. The densitometric analysis of the expresses bands (lower columns) was normalized with that
of β-actin and then calculated as relative to the control group. Values are expressed as mean ± SEM for 8 rats. *Values are significant different (p < 0.5)
compared to control non diabetic group. #Values are significant different (p < 0.5) compared to control diabetic group.
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cretion. Dietary inclusion of curcumin (0.6-0.9 g/kg
diet), improved the adverse effect of aflatoxins in blood
glucose values of broiler chickens [37]. Similar hypoglycemic
effect of curcumin [23] and turmeric rhizomes [18] was ob-
served in alloxan induced diabetes in rats. The medicinal
plants exert its hypoglycemic effect either directly on the
pancreas and subsequent release of insulin or indirectly via

































Figure 3 Real time RT-PCR analysis of IGF-1 (a), Bcl2 (b), SOD (c), CAT
diabetic (D) and Curcumin (Cur) treated diabetic rats. Values are expres
compared to control non diabetic group. #Values are significant different (pgluconeogenesis [22]. The hypoglycemic effect of curcumin
may be attributed to stimulation of polyol pathway in which
glucose converted to sorbitol by the aids of aldose reductase
in the presence of NADPH. This pathway beside its lower-
ing effect of glucose, it enhances the glutathione redox cycle
and subsequent protection against ROS [38]. This was
underlined by the results obtained in the present study indi-



































(d) in liver tissues of control non diabetic (C), experimentally
sed as mean ± SEM for 8 rats. *Values are significant different (p < 0.5)
































Figure 4 Real time RT-PCR analysis of GPX (a) and GST (b) in liver tissues of control non diabetic, experimentally diabetic and
curcumin (Cur) treated diabetic rats. Values are expressed as mean ± SEM for 8 rats. *Values are significant different (p < 0.5) compared to
control non diabetic control. #Values are significant different (p < 0.5) compared to control diabetic group.
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betic rats by 19.3% indicated significant oxidative stress.
The present data of lipid peroxidation come in accord-
ance with the findings of Kakkar et al. [3] and Limaye
et al. [39] who reported a 60 and 78.45% increase at six
weeks of streptozotocin induced diabetes, respectively.
The present findings are in accordance also with previ-
ous report [40] indicated significant increase in TBARS
in STZ diabetic rats. The lipid peroxidation may attri-
bute to the hypoinsulinemia caused by STZ progressive
deterioration of normal pancreatic β-cell function. This
hypoinsulinemia induced an increase in the activity of
fatty acyl Co-A oxidase that initiate the β-oxidation of
fatty acids resulting in lipid peroxidation [41,42]. The
present study showed that, administration of curcumin
significantly normalized the liver TBARS in diabetic rats.
These results are underlined by the significant increase
in concentrations of GSH and activities and expression
of antioxidant enzymes in curcumin treated diabetic rats.
The whole mechanism can be discussed briefly as fellow:
STZ caused damage to β-cells of pancreas and led to
production of ROS and absence of insulin. Hypergly-
cemia and lipid peroxidation were produced as a result
of absence of insulin and high level of ROS, respectively
[35]. Superoxide radicals, hydrogen peroxide and hy-
droxyl radicals are the main ROS which caused damage
to DNA, proteins and other macromolecules and subse-
quent diabetic complications. The natural antioxidant
system consists of numerous antioxidant compounds
and several antioxidant enzymes such as SOD, CAT,
GPX and GST. The primary ROS produced in the aer-
obic organisms is superoxide radical that is a highly re-
active cytotoxic agent. Superoxide radical is converted to
H2O2 by SOD. Further, H2O2 in turn, is converted to mo-
lecular oxygen and H2O by either CAT or GPX. Moreover,
GPX can reduce lipid peroxides and other organic hydro-
peroxides that are highly cytotoxic products. Thus, SOD,
CAT and GPX constitute the principal components of theantioxidant system and their deficiencies can cause oxida-
tive stress. In addition, GSH conjugated with xenobiotic
substances by the aids of GST. Literature with regards to
the effect of oxidative stress on antioxidant enzyme activ-
ities varied significantly from no changes [7], decrease
[22,36,43] and increase [39,44,45] depending on the dur-
ation of the experiments and the age of animals. When
ROS concentrations overwhelms the antioxidant capacity,
oxidative stress is generated with characteristic cell dam-
age. In the present study, GSH concentration was de-
creased significantly in STZ diabetic rats because it was
consumed for conjugation with STZ, a process catalyzed
by GST [22,36]. A significant increase of GST activity has
been observed in STZ diabetic rats to facilitate the conju-
gation process between STZ and GSH [22,36]. In addition,
activities of all antioxidant enzymes were also increased
significantly in these diabetic rats to scavenge the ROS
and avoid diabetic complications. Administration of cur-
cumin to diabetic rats increased GSH and augmented the
increase of antioxidant enzymes activities and even gene
expression of these enzymes to counteract the oxidative
stress. the mechanism applied for enhancement of gene
expression of antioxidant enzymes is beyond the objec-
tives of the current study [22,36,40,43,46]. The present
findings indicated that, the activities of antioxidant en-
zymes were not increased in normal non diabetic rats be-
cause these rats were normal, not diabetic and hence ROS
were not generated and no needs for activation of antioxi-
dant system. The situation was differed in positive control
diabetic rats as STZ destroyed the beta cell of pancreas,
no insulin, high ROS and increasing the activity and even
gene expression of antioxidant enzymes is essential to
counteract the stressful situations. CAT was increased sig-
nificantly in diabetic untreated rats to counteract the in-
creased amount of H2O2. Like CAT, the GPX and SOD
were also increased significantly in diabetic rats to reduce
the lipid peroxides. Similar results [7,8,39] reported an in-
crease in the activities of GPX of diabetic rats. Parallel to
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liver, heart and pancreas was observed in STZ diabetic
rats [7] and diabetic patients [9]. In the contrary, other
works [22,36,43] reported a decrease in the above men-
tioned antioxidant enzyme activities in diabetic rats,
however the mRNA levels have not been examined.
Interestingly, curcumin induced significant elevation of
all examined antioxidant enzymes activities in diabetic
rats compare to non treated diabetic rats and non dia-
betic control rats of the present experiment. This may
attributed to increased availability of GSH in diabetic
rats treated with curcumin compare to non treated dia-
betic rats and diabetic rats. Similar results were ob-
tained in STZ induced diabetes in rats and treated with
curcumin [22,36,43].
Previous report [39] concluded that, STZ elevated the ac-
tivities of antioxidant enzymes by increasing their gene ex-
pression. However, the authors depend on semi-quantitative
PCR analysis. The present study showed that, there are posi-
tive correlation between gene expression and activities of
the antioxidant enzymes in STZ diabetic rats. Moreover, the
gene expression was evaluated by both conventional and
relative quantitative real time RT-PCR. The real time RT-
PCR was performed for confirmation of the conventional
RT-PCR results. In addition, the real time RT-PCR was use-
ful and sensitive than conventional RT-PCR for GST gene
expression analysis. Combining the results of conventional
and real time RT-PCR, STZ induced elevation of mRNA
expression of all antioxidant enzymes and Bcl2. Interest-
ingly, curcumin increased significantly the gene expression
of theses parameters with significant increase also in gene
expression of IGF-1 in STZ diabetic rats compare to un-
treated diabetic rats and non diabetic rats. The significant
increase of SOD, CAT, GPX and GST gene expression in
STZ diabetic rats seems to be a natural response of the
cell to cope with oxidative stress. The significant increase
of gene expression of these antioxidant enzymes in dia-
betic rats treated with curcumin acts as a supplier of new
active enzymes to compensate the loss of antioxidant ac-
tivities which inhibited either by glycation or ROS due to
STZ. In addition, the significant increase in gene expres-
sion of these genes might indicate that these enzymes
were regulated at the transcriptional level. While some re-
searches [39] demonstrated up regulation of gene expres-
sion of antioxidant enzymes in STZ diabetic rats, others
indicated either no significant [28] or decrease [47] in ac-
tivities and gene expression of theses enzymes in diabetic
rats. Curcumin is known to augment antioxidant status
especially through SOD [48,49]. Therefore, in the present
study, by unknown mechanism, curcumin enhanced the
gene expression of SOD which increased approximately 2
fold than control non diabetic and diabetic untreated rats.
The significant elevation of SOD gene expression in dia-
betic rats treated with curcumin than diabetic untreatedrats throughout the experiment indicated that, higher
levels of superoxide radicals were produced which re-
quires immediate dismutation [49]. The present findings
come in accordance with previous results [50] which indi-
cated that curcumin increased hepatic gene expression of
SOD in chicken intoxicated with aflatoxin. Peroxisomal
CAT and cytosolic GPX are involved in the conversion of
H2O2 into water and molecular oxygen [51]. The signifi-
cant increase of gene expression of CAT and GPX in dia-
betic rats treated with curcumin agrees with pervious
results in chicken fed aflatoxin and treated with curcumin
[50]. The insignificant difference of gene expression of
CAT and GPX in untreated diabetic rats and diabetic rats
treated with curcumin may be attributed to the synergistic
effect of both enzymes for destruction of H2O2 produced
by SOD or due to over expression of Bcl2 which is known
as potent antioxidant. The significant elevation of GST
gene expression in untreated diabetic rats as determined
by real time PCR was to conjugate the reactive STZ me-
tabolites with GSH as main step of detoxification process.
The significant increase in gene expression of GST was
more pronounced in diabetic rats treated with curcumin
due to higher availability of GSH in this group. Although,
administration of curcumin up-regulated the gene expres-
sion of antioxidant enzymes, the present study did not
clarified the exact mechanism of action if it is due to dir-
ect or indirect effect of curcumin on the examined genes.
Therefore, the present study recommends further investi-
gation regarding this point.
IGF-1 has similar structures and functions like those
of insulin particularly for peripheral uptake of glucose
and fatty acids [17]. It is a single polypeptide with 70
amino acids and is widely expressed in mammal tissues
[15-17]. The liver is the main source of circulating IGF-1
[52], thus the liver tissues were used for the expression
study. IGF-1 induced its effect via binding to specific re-
ceptors on target cells. Insulin regulates liver IGF-1 ex-
pression either directly or indirectly by increasing the
number of growth hormone hepatic receptors. Because
of, IGF-1 induced glucose taken and improved the insulin
sensitivity [53,54], increased its expression augmented this
effect in diabetic rats treated with curcumin. Therefore,
the increase of gene expression of IGF-1 by curcumin
administration can be considered a new finding related
to the present study, however, the actual mechanism of
action could be subjected to further investigation. In
the present study, liver tissue IGF-1 gene expression
was not significantly changed in STZ diabetic rats
compared to the control non diabetic which disagree
with previous findings [18,55] indicating down regula-
tion of IGF-1 in diabetic rats after acute or chronic ad-
ministration of alloxan. This contradiction might be
due to using different diabetogenic factor, experimental
time and different RT-PCR protocols.
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death via apoptosis. Bcl-2 is an integral mitochondrial
membrane protein and acts as anti apoptotic and anti-
oxidant factor [11]. Bcl-2 reduced the generation of ROS
through binding to cytochrome c or prevents its entry to
the cytosol [12]. There are a close relationship related
the expression of Bcl2 and antioxidant enzymes, increase
the expression of Bcl-2 exhibit elevated expression of
antioxidant enzymes and higher levels of cellular GSH
[13]. The significant increase in the expression of Bcl-2
in diabetic rats compared with control non diabetic rats
was to counteract the oxidative stress arisen by diabetes.
The significant up regulation of Bcl2 gene expression in
diabetic rats treated with curcumin compare to diabetic
untreated rats was to maintain the anti-apoptotic and
antioxidant effect of Bcl2 in diabetic rats. This up regu-
lation was concomitant with up regulation of IGF-1
which indicated that curcumin protected the body of
diabetic rats via hypoglycemic and antioxidant effects.
As discussed above, the anti hyperglycemic effect of cur-
cumin was observed via up-regulation of IGF-1 gene ex-
pression in diabetic rats. Curcumin was antioxidant as
reflected on up-regulation of gene expression and activ-
ities of antioxidant enzymes. Curcumin was antiperoxi-
dative drugs as reflected on increased GSH contents
with subsequent decrease in lipid peroxide biomarkers
(TBARS). The anti-apototic effect of curcumin was also
observed through up-regulation of Bcl2.
Conclusion
The present study suggests that, curcumin can be used
as natural hypoglycemic drugs in diabetic rats. The ad-
ministration of curcumin reduced lipid peroxidation, ele-
vated the glutathione capacity and increased the activities
and gene expression of antioxidants enzymes. In addition,
gene expression of IGF-1 and Bcl2 was also observed. Fur-
ther studies are required to investigate whether the cause
of activation of gene expression was due to a direct effect
of curcumin in the studied enzymes or due to the overall
effect of curcumin that leads to a cascade of reactions that
resulting in the observed changes.
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